409 related articles for article (PubMed ID: 29486130)
1. Treatment of acute exacerbations of interstitial lung disease.
Azadeh N; Moua T; Baqir M; Ryu JH
Expert Rev Respir Med; 2018 Apr; 12(4):309-313. PubMed ID: 29486130
[TBL] [Abstract][Full Text] [Related]
2. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
3. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
Salonen J; Vähänikkilä H; Purokivi M; Kaarteenaho R
PLoS One; 2020; 15(11):e0242860. PubMed ID: 33253258
[TBL] [Abstract][Full Text] [Related]
4. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
5. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Fujitaka K; Hamada H; Hattori N
Respir Investig; 2022 Jul; 60(4):531-542. PubMed ID: 35504814
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbation of interstitial lung disease after procedures.
Amundson WH; Racila E; Allen T; Dincer HE; Tomic R; Bhargava M; Perlman DM; Kim HJ
Respir Med; 2019 Apr; 150():30-37. PubMed ID: 30961948
[TBL] [Abstract][Full Text] [Related]
7. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
10. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbation of interstitial lung disease associated with rheumatic disease.
Luppi F; Sebastiani M; Salvarani C; Bendstrup E; Manfredi A
Nat Rev Rheumatol; 2022 Feb; 18(2):85-96. PubMed ID: 34876670
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.
Ba C; Wang H; Jiang C; Shi X; Jin J; Fang Q
BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413119
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia.
Manfredi A; Luppi F; Cassone G; Vacchi C; Salvarani C; Sebastiani M
Expert Rev Clin Immunol; 2020 Aug; 16(8):751-770. PubMed ID: 32722946
[TBL] [Abstract][Full Text] [Related]
16. Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.
Flechsig P; Hural O; Kreuter M; Eichhorn M; HEUßEL G; Sachpekidis C; Kauczor HU; Haberkorn U; Heussel CP; Eichinger M
In Vivo; 2018; 32(6):1457-1462. PubMed ID: 30348701
[TBL] [Abstract][Full Text] [Related]
17. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
18. Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.
Salonen J; Jansa S; Vähänikkilä H; Kaarteenaho R
BMC Pulm Med; 2023 Jul; 23(1):236. PubMed ID: 37393286
[TBL] [Abstract][Full Text] [Related]
19. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
Wijsenbeek M; Kreuter M; Olson A; Fischer A; Bendstrup E; Wells CD; Denton CP; Mounir B; Zouad-Lejour L; Quaresma M; Cottin V
Curr Med Res Opin; 2019 Nov; 35(11):2015-2024. PubMed ID: 31328965
[No Abstract] [Full Text] [Related]
20. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]